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In sub-Saharan Africa, approximately 30 million pregnant women are at risk of contracting malaria annually. Nearly 36% of healthy
pregnant women receiving routine antenatal care tested positive for Plasmodium falciparum HRP-II antigen in Ghana. We tested
the hypothesis that asymptomatic HRP II positive pregnant women expressed a unique Th1 and Th2 phenotype that diﬀers from
healthy controls. Plasma from healthy (n = 15) and asymptomatic (n = 25) pregnant women were evaluated for 27 biomarkers
(IL-1b, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL- 17, Eotaxin, bFGF-2, G-CSF, GM-CSF, IFN-γ,
IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-bb, RANTES, TNF, and VEGF) associated with Th1 and Th2 cytokine homeostasis. IL-10
and G-CSF levels were elevated in the asymptomatic group when compared with the healthy group (P = .031 and .041, resp.). The
median ratios of IL-1β:5, IL-1β:10, IL-1β:G-CSF, IL-1β:Eotaxin, IL-12:G-CSF, IL-15:10, IL-17:G-CSF, IL-17:Eotaxin, TNF:IL-4,
TNF:IL-5, and TNF:G-CSF were significantly diﬀerent among the two groups. Thus, asymptomatic malaria carriage may be linked
to circulating levels of IL-10 and G-CSF.

1. Introduction
The World Health Organization estimates that around 250
million cases of malaria infections and 1–3 million associated
deaths globally are reported annually [1]. Infection with
Plasmodium falciparum has a wide spectrum of manifestations that are classified into three main clinical groups:
asymptomatic (presence of malaria parasite without malaria
symptoms), mild, and severe malaria. In malaria-endemic
areas, a significant proportion of individuals considered
asymptomatic, harbor parasites without presenting signs of
clinical malaria [2]. The significance of such asymptomatic
infections in the broader context of malaria transmission
has been evaluated in diverse situations using complementary approaches [3–6]. Variant-specific immunity has been
used to explain the low-grade infection during extended

periods without clinical symptoms [7]. Studies suggest
that long-term asymptomatic carriage may represent a
form of tolerance to parasites in individuals such that
asymptomatic carriage may protect these individuals from
developing severe malaria [3–5]. Older individuals are more
likely to develop uncomplicated malaria or asymptomatic
parasitemia [8]. In high malaria endemic areas, protection
from severe malaria is acquired early during childhood,
although it takes longer to be protected from less severe
disease [9]. Although immunoprotective mechanisms clear
a large proportion of infected erythrocytes, a subset persists
in the circulation leading to asymptomatic parasitemia
[4, 9].
Conversely, asymptomatic carriage may represent a mode
of entry to symptomatic malaria, especially in young children [6, 10]. Many asymptomatic infections go undetected
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and untreated while causing little or no clinical manifestation. The extent of the prevalence of asymptomatic
parasitemia in a given population is inversely related to
the population’s susceptibility to clinical disease [11, 12],
but more importantly, asymptomatic individuals are major
reservoirs of infection [13, 14]. Gouagna et al. [15] have
demonstrated that parasites from asymptomatic individuals
are more infectious to mosquitoes than are parasites from
symptomatic individuals. These results have driven current
presumptive intermittent antimalarial treatment strategy
for asymptomatic individuals, regardless of their malaria
infection status, to reduce malaria morbidity and mortality
[16]. Furthermore, field surveys of malaria using microscopy
have often failed to detect very low-level parasitemia, which
is common among asymptomatic patients.
During successful pregnancies, maternal leukocytes produce predominately Th2-type cytokines to prevent initiation
of inflammatory and cytolytic-responses that might damage
the integrity of the placental barrier [17]. In response to
invading pathogens, Th1-type cytokines may be produced
that reverses the Th2-type bias [18]. The deviation in
local and systemic immune response towards a Th2 bias
may leave pregnant woman more open to Th1-dependent
infections such as malaria thereby contributing in increased
morbidity. A previous study in Ghana observed 36.3%
of asymptomatic P. falciparum infection among pregnant
women [19]. Similarly, Gabon and Cameroon have reported
57% and 82.4% asymptomatic infection prevalence respectively [20, 21] suggesting that pregnant women may present
cytokine or chemokine levels that may confer less susceptibility to symptomatic malaria thereby harboring malaria
parasite without showing any symptoms. The current study
examined the immune modulators associated with asymptomatic parasitemia in pregnant women and compared with
health-uninfected controls. The levels of malaria-associated
cytokine, chemokine, and growth factors in asymptomatic
healthy pregnant women were evaluated simultaneously to
characterize and identify potential biological factors induced
by asymptomatic P. falciparum infections that provide
insights into malaria immunopathogenesis as well as targets
for adjunctive therapies to prevent malaria morbidity and
mortalities.

2. Methods
2.1. Study Subjects and Samples. Women who had a singleton
and uncomplicated pregnancy with no clinical symptoms
of malaria presenting at their third trimester for delivery at
two hospitals in Kumasi Ghana, the Komfo Anokye Teaching
Hospital and the Manhyia Polyclinic in Kumasi, November
to December 2006 were enrolled after informed consent.
Medical history before and during pregnancy was obtained
and recorded. 746 women with ages ranging from 15 to
48 were enrolled with an average age of 26.8 years. Venous
blood samples were collected after enrollment. Red blood
cells and plasma were separated and stored at −80◦ C until
ready to use. Hemoglobin levels, malaria antigens in the
blood as well as presence of helminthes in stool samples were
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determined. Malaria antigen levels were determined by using
a Malaria Antigen ELISA kit (CELISA, Cellabs, Australia).
This kit measures HRP II production during growth and
multiplication [22] of P. falciparum at a specificity of 96%
and sensitivity of 98% in whole blood or plasma and
can detect P. falciparum parasites at a limit of detection
of 0.001% [23]. Study participants were categorized into
asymptomatic carriers (ACs) and healthy controls (HCs).
The AC group were positive for HRPII while HC were
negative for HRPII. Determination of hookworms, Ascaris
lumbricoides, Strongyloides stercoralis, and Trichuris trichura
was done as previously described [19]. Stool samples were
processed within 12 hours of collection and examined
microscopically within 1 hour of preparation to avoid
missing hookworm ova [19].
2.2. Multiplexed Microsphere Cytokine Immunoassay. Forty
plasma samples were randomly selected from 746 samples from pregnant women (15 healthy control and 25
asymptomatic carriers) and were evaluated simultaneously
for circulating levels of 17 cytokines (IL-1β, IL-1ra, IL2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12, IL-13, IL15, IL-17, G-CSF, GM-CSF, TNF, IFN-γ), 7 chemokines
(IL-8, Eotaxin, IP-10, MCP-1, MIP-1α, MIP-1β, RANTES),
and 3 growth factors (bFGF-2, PDGF-bb, VEGF) using
a commercially available multiplex bead-based cytokine
assay coupled with the Luminex system (Austin, TX) and
human-specific magnetic beads Bio-Plex Cytokine Kit (BioRad, Hercules, CA). Biological factor levels were measured
using optimal concentrations of standards and antibodies
according to the manufacturer’s instructions. Briefly, plasma
samples were diluted 1 : 4 in Bio-Plex sample diluents and
an eight point, broad range cytokine standard was prepared
by serial dilution from a cytokine stock. Fifty microliters
of diluted sample or standard were transferred to 96well filtration plate containing anticonjugated beads. The
plate was shaken for 30 seconds at 1,100 rpm, reduced to
300 rpm, and incubated for 60 minutes at room temperature.
After incubation and washes, detection antibody (2 mg/mL)
was added and incubated for 30 minutes. After 3 washes,
streptavidin-PE was added and incubated for 10 minutes.
Beads were mixed before reading on the Bio-Plex Suspension
Array System. The data was analyzed using Bio-Plex Manager
software with 5-parameter logistic (5PL) regression curves.
2.3. Statistical Analysis. To normalize the distribution of
cytokine values, the data was log transformed. Diﬀerences in
individual biological factor concentrations between HC and
AC groups were compared using nonparametric KruskalWallis one-way analysis of variance (ANOVA) on ranks.
Dunn’s method was used for all pairwise multiple comparison procedures to isolate the group or groups that diﬀer from
the others. The diﬀerences in proinflammatory or angiostatic
to anti-inflammatory or angiogenic cytokine median ratios
were compared between the two groups using ANOVA to
determine the balance or disequilibrium of Thl and Th2
determinants between the groups. Box plots of median
biomarker concentrations with 25th and 75th percentiles
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Table 1: Description of the pregnant women in the study. HC
denotes healthy control and AC denotes asymptomatic carrier. The
values for hemoglobin was mean ± SD.
HC
15
Negative

AC
25
Positive

12.63 ± 1.17 10.98 ± 2.32
13
0
0
0
0
0
0

P-value

.017

44
2
1
1
0
0
0

log10 IL-10 concentration (pg/mL)

Characteristics
No. of Subjects
HRP II/Malaria
Mean Hemoglobin Level
(g/dL)
% Anemia (Hb < 11 g/dL)
Ascaris Infection
Hookworm Infection
Trichiuris Infection
Strongyloides Infection
Enterobius Infection
Taenia Infection

∗

100

10

1
HC

3. Results
3.1. Patient Characteristics. Nearly one-third (30.2%) of the
746 participants were primigravidae and 98.7% had at least
one prenatal visit prior to delivery with most occurring
in the third trimester of pregnancy [19]. However, among
the 40 random samples selected for the present study, the
participants were at least secundigravidae. The prevalence
of P. falciparum among the participants was 36% and
16.6% had malarial and helminth coinfection [19]. Out
of the 40 randomly selected samples, 13% HC and 44%
AC were anemic (hemoglobin < 11 g/dL) (Table 1). The
mean hemoglobin levels were significantly higher in the HC
(12.63 ± 1.17) than AC (10.98 ± 2.32), P = .017. None of the
HC had helminth infection and 16% of the AC samples had
one or multiple helminth infection. The helminth infection
did not appear to aﬀect the anemic outcome observed in the
AC group (Table 1).
3.2. Biomarker Levels in Healthy Controls and Asymptomatic
Carriers. Pairwise comparisons were used to determine the
levels of significance of the diﬀerences between the plasma
biological factor levels of the two groups (HC and AC)
after controlling for age and primigravidae. The plasma
levels of 27 biological factors were grouped into proinflammatory, anti-inflammatory, and angiogenic/angiostatic
biomarkers and analyzed. The proinflammatory and angiogenic/angiostatic levels demonstrated marginal changes but
did not show statistically significant diﬀerences between
the HC and AC groups (data not shown). Among the
anti-inflammatory biomarkers evaluated, IL-10 and G-CSF
were significantly (P < .05) elevated among the AC group
compared to HC group (Figure 1). In addition, among the

AC
(a)

1000

log10 G-CSF concentration (pg/mL)

were plotted. Values outside the bars for 10th and 90th
percentiles were plotted as points. Statistical significance
for each biological factor was set at a two-tailed P < .05.
SigmaPlot software version 10 (Systat Software Inc., San Jose,
CA) was used to calculate statistics and plot graphs.

∗

100

10

1
HC

AC
(b)

Figure 1: Concentration of plasma IL-10 and G-CSF in pregnant
women with asymptomatic malaria (n = 25) and healthy controls
(n = 15). Box plots represent median log concentration (pg/ml) and
25th and 75th percentiles. Outliers are shown as points outside the
10th and 90th percentile bars. HC represents healthy controls. AC
denotes asymptomatic carriers. ∗ P < .05 is statistically significant.

AC group comparing helminth infection with absence of
helminth infection, there were no significant diﬀerences
in the peripheral biological factor levels suggesting that
helminth infection did not influence the peripheral biological factor levels.
3.3. Biomarker Ratios in Healthy Controls and Asymptomatic
Carriers. To determine the influence of parasite antigen
on Th1and Th2 homeostasis, plasma proinflammatory
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Table 2: Comparison of selected plasma biomarker median ratios
between the HC and AC Group. Statistical comparison of median
ratios of proinflammatory, angiostatic versus anti-inflammatory
and angiogenic factors in diﬀerent subject groups. P < .05
considered statistically significant.
Proinflammatory or Angiostatic
versus Anti-inflammatory or
Angiogenic Biomarker Median
Ratio
IL-1β:IL-5
IL-1β:IL-10
IL-1β:G-CSF
IL-1β:Eotaxin
IL-12:G-CSF
IL-15:IL-10
IL-17:G-CSF
IL-17:Eotaxin
TNF:IL-4
TNF:IL-5
TNF:G-CSF

AC

HC

Overall P
Value

2.73
0.74
0.21
0.18
0.261
0.163
1.102
1.004
15.335
9.974
0.831

3.31
1.06
0.33
0.31
0.420
0.848
1.723
1.627
24.518
15.510
1.855

.021
.040
.003
.001
.040
.039
.036
.030
.047
.031
.002

(IL-1β, IL-2, IL-6, IL-8, IL-12, IL-15, IL-17, GM-CSF, IFNγ, MCP-1, MIP-1α, MIP-1β, RANTES, TNF) or angiostatic
(IP-10, IL-12) to anti-inflammatory (IL-1ra, IL-4, IL-5, IL6, IL-9, IL-10, IL-13, G-CSF, Eotaxin) or angiogenic (IL-7,
IL-8, bFGF-2, PDGF-bb, VEGF) cytokine median ratios were
compared between the two groups (HC and AC). Comparing
the median ratios of proinflammatory to anti-inflammatory
factors and angiogenic to angiostatic biomarkers among
HC and AC groups, biomarker median ratios (IL-1β:5, IL1β:10, IL-1β:G-CSF, IL-1β:Eotaxin, IL-12:G-CSF, IL-15:10,
IL-17:G-CSF, IL-17:Eotaxin, TNF-α:IL-4, TNF:IL-5, TNFα:G-CSF) were statistically diﬀerent among HC and AC
(Table 2).

4. Discussion
Asymptomatic malaria (presence of malaria parasite without
symptoms) is prevalent in highly endemic areas in Africa
[24]. It is suggested that asymptomatic parasitemia confers partial immunity and protection against symptomatic
malaria [5, 25]. On the other hand, asymptomatic individuals constitute a remarkably large reservoir for malaria
transmission or could be a precursor in the progression of
symptomatic form of malaria. This study was conducted
after reviewing data generated in a previous study [19] and
finding a remarkably high number (36%) of asymptomatic
patients recorded as healthy controls. We acknowledge that
the cross sectional measurement of parasitemia and biological factor levels in host blood and the lack of follow-ups
to determine the true impact of asymptomatic parasitemia
is a limitation of this study. Nevertheless, the importance of
our observation is predicated on recent studies that indicate
that individuals with asymptomatic parasitemia may have a
higher risk of developing symptomatic malaria than those

without evidence of parasitemia [26]. In our study, the AC
group had lower hemoglobin level compared to the HC
group (Table 1). This lower level of hemoglobin could be
due to the presence of chronically low parasitemia causing
extensive destruction of red blood cells. Many asymptomatic
infections are undetected by microscopy and thus most
asymptomatic individual do not receive required treatment
thereby rendering them susceptible to the risks associated
with both symptomatic and asymptomatic malaria. This
persistent problem has resulted in the proposed presumptive
intermittent treatment strategy for asymptomatic individuals, regardless of their malaria infection status, to reduce
malaria morbidity and mortality [16]. This therapeutic
method may adversely result in accelerating the development
of resistance against anti-malarial drugs suggesting an urgent
need to determine the true infection status before treatment.
This approach is useful in decreasing the prevalence of
asymptomatic malaria and the negative consequence of drug
resistance to anti-malarial drugs.
The present study examined a broad range of immune
mediators, including cytokines, chemokines, and markers
of apoptosis and angiogenesis in healthy and asymptomatic
malaria carrier pregnant women. The immunological relevance of these biological factors associated with asymptomatic malaria have been previously established [27, 28].
Due to the lack of concurrent studies of inflammatory,
apoptotic, and angiogenic factors in appropriate timematched symptomatic patients, the results are discussed in
context. Proinflammatory Th1-type cytokines are thought to
be critical to the control of exoerythrocytic and erythrocytic
P. falciparum infection [29, 30], but their exaggerated production may also contribute to organ damage, particularly
in the brain in cerebral malaria cases. It is widely accepted
that anti-inflammatory Th2-type cytokines downregulate
Th1-derived cytokines. Th2-type cytokines, such as IL-10,
regulate Th1-cytokines and prevent severe forms of malaria
in some animal models [31]. The regulation of TNF levels
by IL-10 appears to contribute to the prevention of severe
malarial anemia in humans [32–34]. However, the role that
IL-10 plays may depend on its levels, since very high levels
of IL-10 have been associated with severe malaria in humans
[35] and some animal models [36]. In our analysis, higher
levels of IL-10 were observed in the AC group than the HC
group. IL-10 is a key cytokine involved in both protection
and immunopathology during malaria. High levels of IL-10
may be beneficial by reducing the inflammatory response,
but may be detrimental by decreasing antiparasitic cellular
immune responses. IL-10 is an anti-inflammatory cytokine
that acts in part by blocking monocyte and macrophage
production of inflammatory cytokines such as IL-6, TNF,
and IL-l [37]. Animal studies have suggested that IL-10
may play a regulatory role that modulates susceptibility to
parasite infection. In particular, IL-10 inhibits microbicidal
activity of IFN-γ-treated macrophages against intracellular
parasites such as Toxoplasma gondii [38], Trypanosoma
cruzi [39] and Leishmania major [40], and the killing of
extracellular Schistosoma mansoni schistosomulas [41]. IL-10
has been previously observed to be elevated during malarial
episodes in nonpregnant [42, 43] and pregnant women [44].
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Both increased and decreased levels of IL-10 have been
associated with poor malaria outcomes. Low levels of IL10 or low IL-10 to TNF ratios were associated with severe
malarial anemia in African children [32, 34], while high IL10 levels were associated with reduced ability to eliminate
malaria parasitemia in Tanzanian children [45]. Thus, the
high levels of IL-10 observed in the AC group may reduce
their ability to eliminate or clear malaria parasitemia as seen
in the HC.
Cytokines may stimulate beneficial immunological
responses in falciparum malaria by inducing acute phase
responses, inhibition of parasitic growth, and clearance of
vascular parasites and debris. Neutrophils are stimulated by
cytokines such as TNF or INF-γ in order to increase parasite
destruction [46]. In the present study, it seems that G-CSF
may be involved in controlling P. falciparum parasitemia,
which ultimately results in the asymptomatic condition
observed in our AC group. G-CSF has both anti-infective and
anti-inflammatory eﬀects [47]. G-CSF enhances phagocytosis and increases chemotaxis and antibody-dependent cytotoxicity suggesting its involvement in anti-malarial defense
by activating neutrophils and acting as an immunomodulatory factor [47]. Surprisingly, G-CSF levels were elevated
in the AC compared to HC suggesting that this factor may
be involved in maintaining low parasitemia levels observed
in the asymptomatic individual. Functional studies on the
association of G-CSF and IL-10 with asymptomatic malaria
are much needed to reveal their contribution to the spread
and severity of malaria.
Maternal leukocytes produce predominately Th2-type
cytokines shifting the cytokine balance towards Th2-type
response during pregnancy to prevent initiation of inflammatory that might damage the integrity of the placental
barrier [17]. In response to invading pathogens,Th1-type
cytokines may be produced to reverse the Th2-type bias
[18] to aid in elimination of parasites by enhancing phagocytic activity of macrophages, generating reactive oxygen
intermediates, and stimulating the proliferation of T cells
[48]. However, our median ratio result indicates that there
was significance bias towards a Th2-type profile in the AC
group with low pro- to anti-inflammatory ratios compared
to the HC group (Table 2). This deviation in immune
response towards a Th2 bias may explain the asymptomatic
observation in the AC group due to the fact that this
group has a less robust Th1-type response to eliminate
malaria parasites compared to the HC group. In addition,
the Th2 bias may leave pregnant AC more open to Th1dependent infections that may result in increased morbidity
in pregnancy.
We acknowledge that this study has limitations that
can be investigated in future studies. The current study
did not include cytokine profiles of nonpregnant women
and pregnant women with malaria as well as asymptomatic
nonpregnant women to determine whether our observations
were unique to pregnant women. However, IL-10 has been
observed to be elevated during malarial episodes in nonpregnant [42, 43] and pregnant women [44]. Although our study
lacked malaria positive pregnant women, comparing the
results to other studies in which malaria positive pregnant

5
women were included suggests that the levels of peripheral
IL-10 in the AC group were lower than pregnant women
with placental malaria [49]. In addition, studies in murine
models of malaria have suggested that IL-10 response during
infection may be associated with the disease exacerbation
[36].
To the best of our knowledge, there are no comprehensive prospective studies that describe cytokine profile
during pregnancy, therefore, we do not know whether the
observation made in this study may have been influenced
by pregnancy-specific conditions. However, the increase in
asymptomatic cases [19–21, 50, 51] highlights the alarming
potential of malaria as a serious public health issue underscoring the need for tighter surveillance [50]. Asymptomatic
individuals not only serve as a source of maintenance of
intense malaria transmission during the peak season but
could also perpetuate resistance through the inappropriate
use of drugs [51].
In summary, cytokine, chemokine, and growth factor
evaluation in asymptomatic healthy pregnant women reveal
an association between increased plasma concentrations
of IL-10 and G-CSF. Thus, susceptibility to symptomatic
malaria in pregnancy may be associated with high levels
of IL-10 and G-CSF and dysregulation of pro and antiinflammatory factors in pregnant women. In the absence of
studies explaining the functional implication of this finding
for the asymptomatic condition observed in these pregnant
women, we propose that assessment of these biological
factors in conjunction with rapid detection of P. falciparum
HRP-II and PCR-based methods could be a useful tool for
predicting risk for asymptomatic malaria carriage.
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